Avia Merenlender‐Wagner
Teva Pharmaceuticals (Israel)(IL)Teva Pharmaceuticals (Czechia)(CZ)
Publications by Year
Research Areas
Schizophrenia research and treatment, Autophagy in Disease and Therapy, Treatment of Major Depression, Health Systems, Economic Evaluations, Quality of Life, Neuropeptides and Animal Physiology
Most-Cited Works
- → Autophagy has a key role in the pathophysiology of schizophrenia(2013)232 cited
- → New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia(2014)78 cited
- → ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease(2017)57 cited
- → The β-Endorphin Role in Stress-Related Psychiatric Disorders(2009)56 cited
- → NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse—A microtubule-deficient model of schizophrenia(2010)56 cited
- → Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria(2023)26 cited
- → Cognitive disturbances in the cuprizone model of multiple sclerosis(2020)18 cited
- → The SOLARIS protocol: a phase 3, randomized, double-blind, placebo-controlled trial assessing safety and efficacy of TV-44749 in adults with schizophrenia(2023)2 cited
- → NAP (davunetide) mechanism of microtubule/autophagy protection: discovery of new therapeutic targets and pipeline products(2014)
- → Effects of Long-Term Treatment with TV-46000 on Symptom Improvement Over Time in Stabilized Patients with Schizophrenia(2025)